View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

KLA Corp: 1 director

A director at KLA Corp sold 3,537 shares at 699.160USD and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showin...

Invisio AB: 1 director

A director at Invisio AB sold 12,000 shares at 227.440SEK and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...

Qatar National Cement Co: 1 director

A director at Qatar National Cement Co sold 106,900 shares at 0.000QAR and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...

Transmedics Group Inc: 5 directors

Five Directors at Transmedics Group Inc sold after exercising options/sold 61,218 shares at between 128.000USD and 130.070USD. The significance rating of the trade was 95/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades b...

Nuvalent Inc: 1 director

A director at Nuvalent Inc sold 37,500 shares at 69.481USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...

Shell Plc: 1 director

A director at Shell Plc sold 47,281 shares at 33.871EUR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...

Singular People S.A: 1 director

A director at Singular People S.A bought 13,625 shares at 3.113EUR and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...

Lemaitre Vascular Inc: 1 director

A director at Lemaitre Vascular Inc sold 5,025 shares at 75.620USD and the significance rating of the trade was 60/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...

Caleres Inc: 1 director

A director at Caleres Inc sold 25,332 shares at 37.627USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...

Adobe Inc: 1 director

A director at Adobe Inc sold 795 shares at 490.100USD and the significance rating of the trade was 58/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing...

Duni AB: 1 director

A director at Duni AB bought 4,700,000 shares at 118.000SEK and the significance rating of the trade was 99/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...

HCA Healthcare Inc: 1 director

A director at HCA Healthcare Inc sold/gave away 6,100 shares at 0.000USD and the significance rating of the trade was 58/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...

JP Morgan Chase & Co: 4 directors

Four Directors at JP Morgan Chase & Co gave away/sold 35,355 shares at between 0.000USD and 193.660USD. The significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's dir...

United Development Co: 1 director

A director at United Development Co bought 2,635,768 shares at 0.000QAR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...

Barwa Real Estate: 1 director

A director at Barwa Real Estate sold 269,990 shares at 0.000QAR and the significance rating of the trade was 66/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...

Medpace Holdings Inc: 1 director

A director at Medpace Holdings Inc sold 52,404 shares at 403.201USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...

Moody's assigns A1 to City of Yokohama's domestic bonds due November 2...

1/4NEWSContact:東京 東京粟野 幸子 セメトコ 真理子主任格付アナリスト/アナリスト 格付責任者/アソシエイト・マネージング・ディレクターサブソブリン・グループ コーポレート・ファイナンス・グループムーディーズ・ジャパン株式会社 ムーディーズ・ジャパン株式会社お客様専用電話番号:03-5408-4100報道関係者電話番号:03-5408-4110お客様専用電話番号:03-5408-4100報道関係者電話番号:03-5408-4110[MJKK]横浜市が発行する債券にA1の格付を付与  2024年5月9日、東京、ムーディーズ・ジャパン株式会社は、以下の格付を付与したことを公表...

Moody's Ratings upgrades ratings on notes from two Brighte Green Trust...

Moody's Ratings (Moody's) has upgraded the ratings on nine classes of notes issued from two Brighte Green Trust transactions. IMPORTANT NOTICE: MOODY'S RATINGS AND PUBLICATIONS ARE NOT INTENDED FOR USE BY RETAIL INVESTORS. SUCH USE WOULD BE RECKLESS AND INAPPROPRIATE. SEE FULL DISCLAIMERS BELOW. ...

Moody's Ratings assigns provisional ratings to two classes of notes to...

Moody's Ratings (Moody's) has assigned provisional ratings to two classes of notes to be issued by Hildene TruPS Resecuritization A10BC, LLC (the "Issuer").   Moody's rating action is as follows: U.S.$38,000,000 Class A Notes due 2036, Assigned (P)Baa3 (sf) U.S.$16,000,000 Class B Notes due 203...

Arsit Pamaranont
  • Arsit Pamaranont

Star Petroleum Refining (SPRC TB) - 1Q24: Results In Line With Expecta...

SPRC reported 1Q24 net profit of Bt3.9b, above our estimate by 22%, due to higherthan- expected inventory gain of Bt1.4b. Excluding one-off items (inventory gain, forex gains and insurance claim), SPRC’s core profit was Bt2.2b, in line with our estimate. 1Q24 core profit accounted for 44% of our full-year forecast. We believe the market is still concerned about delays in reopening SPM and potentially weaker earnings in 2Q24. Maintain HOLD. Target price: Bt9.50.

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch